Nobel Biocare Holding AG (Nobel Biocare Holding AG) Capex-to-Revenue : 0.02 (As of Dec. 2013)

Nobel Biocare Holding AG Capex-to-Revenue Chart

Nobel Biocare Holding AG Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Capex-to-Revenue		Get a 7-Day Free Trial					0.04	0.05	0.03	0.02	0.02

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Capex-to-Revenue	Get a 7-Day Free Trial							0.04	0.05	0.03	0.02	0.02

Competitive Comparison of Nobel Biocare Holding AG's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nobel Biocare Holding AG's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's Capex-to-Revenue falls into.

Nobel Biocare Holding AG Capex-to-Revenue Calculation

Nobel Biocare Holding AG's Capex-to-Revenue for the fiscal year that ended in Dec. 2013 is calculated as

Nobel Biocare Holding AG's Capex-to-Revenue for the quarter that ended in Dec. 2013 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobel Biocare Holding AG  (OTCPK:NBHGF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Nobel Biocare Holding AG Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description